HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $88.00 billion. The enterprise value is $136.78 billion.
Important Dates
The last earnings date was Friday, April 24, 2026, before market open.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Jun 16, 2026 |
Share Statistics
HCA Healthcare has 221.84 million shares outstanding. The number of shares has decreased by -9.09% in one year.
| Current Share Class | 221.84M |
| Shares Outstanding | 221.84M |
| Shares Change (YoY) | -9.09% |
| Shares Change (QoQ) | -1.76% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 66.80% |
| Float | 149.50M |
Valuation Ratios
The trailing PE ratio is 13.65 and the forward PE ratio is 12.84. HCA Healthcare's PEG ratio is 1.29.
| PE Ratio | 13.65 |
| Forward PE | 12.84 |
| PS Ratio | 1.15 |
| Forward PS | 1.10 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.10 |
| P/OCF Ratio | 6.77 |
| PEG Ratio | 1.29 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.79, with an EV/FCF ratio of 17.25.
| EV / Earnings | 20.13 |
| EV / Sales | 1.79 |
| EV / EBITDA | 8.79 |
| EV / EBIT | 11.42 |
| EV / FCF | 17.25 |
Financial Position
The company has a current ratio of 0.83
| Current Ratio | 0.83 |
| Quick Ratio | 0.64 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.00 |
| Debt / FCF | 6.29 |
| Interest Coverage | 5.24 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.34% |
| Return on Invested Capital (ROIC) | 21.10% |
| Return on Capital Employed (ROCE) | 28.38% |
| Weighted Average Cost of Capital (WACC) | 8.22% |
| Revenue Per Employee | $238,713 |
| Profits Per Employee | $21,231 |
| Employee Count | 320,000 |
| Asset Turnover | 1.26 |
| Inventory Turnover | 25.67 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.98 billion in taxes.
| Income Tax | 1.98B |
| Effective Tax Rate | 20.20% |
Stock Price Statistics
The stock price has increased by +2.53% in the last 52 weeks. The beta is 1.19, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +2.53% |
| 50-Day Moving Average | 467.90 |
| 200-Day Moving Average | 462.00 |
| Relative Strength Index (RSI) | 24.61 |
| Average Volume (20 Days) | 1,491,662 |
Short Selling Information
The latest short interest is 4.33 million, so 1.95% of the outstanding shares have been sold short.
| Short Interest | 4.33M |
| Short Previous Month | 3.63M |
| Short % of Shares Out | 1.95% |
| Short % of Float | 2.90% |
| Short Ratio (days to cover) | 4.03 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $76.39 billion and earned $6.79 billion in profits. Earnings per share was $29.07.
| Revenue | 76.39B |
| Gross Profit | 31.79B |
| Operating Income | 11.97B |
| Pretax Income | 9.79B |
| Net Income | 6.79B |
| EBITDA | 15.57B |
| EBIT | 11.97B |
| Earnings Per Share (EPS) | $29.07 |
Full Income StatementBalance Sheet
The company has $1.06 billion in cash and $49.85 billion in debt, with a net cash position of -$48.78 billion or -$219.89 per share.
| Cash & Cash Equivalents | 1.06B |
| Total Debt | 49.85B |
| Net Cash | -48.78B |
| Net Cash Per Share | -$219.89 |
| Equity (Book Value) | -2.98B |
| Book Value Per Share | -28.32 |
| Working Capital | -3.21B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $13.00 billion and capital expenditures -$5.07 billion, giving a free cash flow of $7.93 billion.
| Operating Cash Flow | 13.00B |
| Capital Expenditures | -5.07B |
| Depreciation & Amortization | 3.59B |
| Net Borrowing | 3.11B |
| Free Cash Flow | 7.93B |
| FCF Per Share | $35.73 |
Full Cash Flow StatementMargins
Gross margin is 41.61%, with operating and profit margins of 15.67% and 8.89%.
| Gross Margin | 41.61% |
| Operating Margin | 15.67% |
| Pretax Margin | 12.82% |
| Profit Margin | 8.89% |
| EBITDA Margin | 20.38% |
| EBIT Margin | 15.67% |
| FCF Margin | 10.38% |
Dividends & Yields
This stock pays an annual dividend of $3.12, which amounts to a dividend yield of 0.77%.
| Dividend Per Share | $3.12 |
| Dividend Yield | 0.77% |
| Dividend Growth (YoY) | 8.70% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.32% |
| Buyback Yield | 9.09% |
| Shareholder Yield | 9.87% |
| Earnings Yield | 7.72% |
| FCF Yield | 9.01% |
Dividend DetailsAnalyst Forecast
The average price target for HCA Healthcare is $510.95, which is 28.81% higher than the current price. The consensus rating is "Buy".
| Price Target | $510.95 |
| Price Target Difference | 28.81% |
| Analyst Consensus | Buy |
| Analyst Count | 25 |
| Revenue Growth Forecast (5Y) | 6.04% |
| EPS Growth Forecast (5Y) | 13.71% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.62 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.62 |
| Piotroski F-Score | 7 |
